Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council | Virpax Pharmaceuticals

Jun 26, 2023

Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council

admin2023-06-27T20:47:40-04:00June 26th, 2023|Media|

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma